Patent ID: 7410992
Filing Date: 2008-08-12
Classification: A61P,C07D,C07F

Abstract:
1. A compound of the structural formula I: or a pharmaceutically acceptable salt, in vivo hydrolysable ester, enantiomer, diastereomer or mixture thereof: wherein, R represents hydrogen, or C R R X represents —(CHR Y represents —CO(CH Q represents CRy; Ry represents H, or C R R R or, R R represents C 6-10 aryl or C 3-10 heterocyclyl, said aryl or heterocyclyl optionally substituted with 1-3 groups selected from R a ; Z represents (CH R* represents hydrogen, or C R R R Z g is 0-1; m is 0-3; n is 0-3; and p is 0-3.